Skip to main content
Caplight Logo









Pacegenix

Pacegenix

Private
Cambridge, MassachusettsAI, Data & Cloud Infrastructurehttps://pacegenix.com/

Last Round

Early Stage

VC

Mar 26, 2026

Company Overview

Pacegenix is a biotechnology company that develops precision cardiology therapeutics designed to treat heart rhythm disorders and improve outcomes in patients with complex arrhythmias.

Sector

AI, Data & Cloud Infrastructure

Verticals

Cloud Infrastructure, Workflow Automation, DevOps & Containers

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

custom software developmentIT consultingdigital transformationmanaged IT servicessoftware engineeringIT outsourcingapplication engineeringinfrastructure supportprocess modernizationtech advisorysoftware housemanaged services providerMSPdigital agency

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pacegenix Comparables

Compare Pacegenix with similar companies based on industry and business-model similarity.

No public comparables are available for Pacegenix. Request access to learn about comparables coverage.

Request access

Pacegenix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early Stage VCMar 26, 2026

Pacegenix Investors

Notable investors and investment history

Pacegenix investors
InvestorRounds
Genesis BioCapitalEarly Stage VC, Accelerator
Eshelman VenturesEarly Stage VC
aMoonEarly Stage VC
LDV PartnersEarly Stage VC

Pacegenix Filings

Explore SEC and related filing metadata, where available.

Pacegenix filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Pacegenix's valuation, stock price, and market status.

Is Pacegenix a public or private company?

Pacegenix is a private company.

What is the current stock price of Pacegenix?

Pacegenix is a private company with no public stock price. No recent secondary market data is available.

How much is Pacegenix worth (valuation)?

Valuation information for Pacegenix is not publicly available.

Can I buy Pacegenix stock?

Pacegenix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Pacegenix's last funding round?

Pacegenix's most recent funding round was Early Stage VC on March 26, 2026.

Who are the main investors in Pacegenix?

Investor information for Pacegenix is not publicly disclosed.

Will Pacegenix IPO soon?

No public IPO plans have been announced for Pacegenix.

How can I track Pacegenix secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pacegenix's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge, Massachusetts
Year Founded2024
Last FundingMar 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?